Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

742
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
742
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

218
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
218
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Interpretable prediction and generation of ASC-speck aptamers using multiscale deep biological learning models.

Bioinformatics advances·2026
Same author

RPI-PLMGNN: Enhancing RNA-Protein Interaction Prediction with the Pretrained Large Language Models and Graph Neural Networks.

ACS synthetic biology·2026
Same author

MPMFMol: Multitask Self-Supervised Pretraining with Multimodal Fine-Tuning for Molecular Property Prediction.

Journal of chemical information and modeling·2026
Same author

Quantum computing applications in drug discovery.

Briefings in bioinformatics·2026
Same author

MuFGPS: enhancing liquid-liquid phase separation protein prediction through multi-level features and ensemble learning.

Briefings in bioinformatics·2026
Same author

Deep learning the TF regulatory code for gene expression.

Genome research·2026

相关实验视频

Updated: Jul 14, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

通过特征处理方案优化药物向亲和力预测方法.

Xiaoqing Ru1, Quan Zou2,3, Chen Lin4

  • 1Department of Computer Science, University of Tsukuba, Tsukuba, Japan.

Bioinformatics (Oxford, England)
|October 9, 2023
PubMed
概括

功能优化对于准确的药物向亲和力 (DTA) 预测模型至关重要. 基于回归树的特征选择提高了模型性能和可解释性,识别了用于改进DTA预测的关键特征.

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

239

相关实验视频

Last Updated: Jul 14, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

239

科学领域:

  • 计算化学和化学信息学
  • 生物信息学和计算生物学
  • 药理学和药物发现

背景情况:

  • 药物向亲和力 (DTA) 预测模型对于药物发现至关重要,但由于复杂的特征工程,往往缺乏可解释性.
  • 目前用于药物和目标特征提取的方法可能会导致冗余或高维特征集,阻碍模型性能和稳定性.
  • DTA预测模型的性能和可解释性受到特征提取和优化的质量的影响.

研究的目的:

  • 开发高度准确和可解释的药物向亲和力 (DTA) 预测模型.
  • 调查各种特征选择和维度减少技术对DTA预测性能的影响.
  • 识别最佳特征子集,以提高模型的准确性,稳定性和可解释性.

主要方法:

  • 应用传统和先进的特征选择和缩小维度的技术来处理药物和目标特征.
  • 采用了学习到等级的方法,并优化了用于高效DTA预测的功能.
  • 采用沙普利增量解释 (SHAP) 值和增量特征选择来识别具有高影响的特征子集.

主要成果:

  • 基于回归树的特征选择成为构建强大和高性能DTA预测模型的最有效方法.
  • 确定了特定特征子集 (顶部150D和顶部20D特征),可显著提高DTA预测准确度.
  • 证明了优化的功能会带来更好的模型性能,稳定性和可解释性.

结论:

  • 功能优化是开发高性能和可解释的DTA预测模型成功的关键决定因素.
  • 该研究为DTA预测中的特征选择和优化提供了经过验证的框架,为未来的模型开发提供了洞察力.
  • 这些发现激发了创建更透明和更有效的药物发现计算工具的想法.